Across TCGA cell cohorts, LRRC3C RNA expression is significantly associated with the go_rna of many other GO terms, with 907 significant associations in total. BLOOD_Lymphoma shows the largest number of these associations.

The most reproducible LRRC3C-associated GO terms across cancer lineages are Negative regulation of immune effector process, ERAD pathway, and Vesicle targeting, rough ER to cis-Golgi. Each is linked with LRRC3C in more than 3 cancer types. Because this analysis shows association rather than direction, both LRRC3C-to-partner and partner-to-LRRC3C results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (LRRC3C→partner) and Y-score (partner→LRRC3C) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Lymphoma	Negative regulation of immune effector process →	+0.063	+0.046	.004	.003	3	4
BLOOD_Lymphoma	ERAD pathway →	+0.048	+0.088	<.001	<.001	3	4
BLOOD_Lymphoma	Vesicle targeting, rough ER to cis-Golgi →	+0.046	+0.073	.004	<.001	3	4
BLOOD_Lymphoma	Pyrimidine nucleoside monophosphate metabolic process →	-0.057	-0.065	<.001	.001	3	4
CNS	Myosin filament organization →	-0.309	-0.024	.001	.003	3	4
CNS	Myosin filament assembly →	-0.309	-0.024	.001	.003	3	4

Each partner links to its Q-omics profile. Showing the 6 strongest of 907 associations by consensus.

Exploration

LRRC3C survival (RNA) · tumor vs normal (RNA) · all LRRC3C data types